SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001078782-17-001212
Filing Date
2017-08-24
Accepted
2017-08-24 17:16:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 REGISTRATION STATEMENT s3_s3.htm S-3 195901
2 EXHIBIT 5.1 OPINION OF PROCOPIO, CORY, HARGREAVES & SAVITCH s3_ex5z1.htm EX-5.1 8518
3 EXHIBIT 23.1 CONSENT OF RBSM LLP s3_ex23z1.htm EX-23.1 3173
4 IMAGE s3_ex5z11.jpg GRAPHIC 33315
5 IMAGE s3_s31.jpg GRAPHIC 50784
  Complete submission text file 0001078782-17-001212.txt   323439
Mailing Address 5 ROCKEFELLER PLAZA 20TH FLOOR NEW YORK NY 10022
Business Address 5 ROCKEFELLER PLAZA 20TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-220155 | Film No.: 171049945
SIC: 2834 Pharmaceutical Preparations